“The bottom line is that if we do see real disappointment in stimulus or the vaccine, then a 10% correction is the likely best-case scenario, and it’ll come…” said Tom Essaye of The Sevens Report, in a note. Click here to read the full article.
Tom Essaye intereviewed with Oliver Renick from TD Ameritrade discussing ISM non-manufacturing, COVID-19 trends, stimulus and more…Click here to watch the full interview.
Yahoo Finance’s Brian Sozzi and Alexis Christoforous break down latest market action with The Sevens Report Founder, Tom Essaye. Click here to watch the full interview.
Tom Essaye – Sevens Report Founder and President weighs on on current market moves with Adam Shapiro and Julie Hyman on Yahoo Finance’s On The Move. Click here to watch the full interview.
“To be clear, from an actual policy standpoint, it’s universally expected that the Fed won’t make any changes to 1) Rates…” wrote Tom Essaye, editor of the Sevens Report. Click here to read the full article.
On Monday, Oxford University and AstraZeneca announced promising results from an early phase human trail of its vaccine candidate. In the face of growing hopes for a coronavirus vaccine, investors have been bidding up stocks aggressively, despite mounting bad news about new COVID-19 infections.
Yet Tom Essaye, founder of the Sevens Report, told Yahoo Finance on Monday that markets are downplaying key problems associated with vaccine development. Currently, drug giants Pfizer (PFE), Johnson & Johnson (JNJ), AstraZeneca…Click here to read the full article.
Sevens Report Research Founder Tom Essaye speaks with Yahoo Finance’s Alexis Christoforous, Brian Sozzi and Jared Blikre about the latest market moves. Click here to watch the full interview.
Tom Essaye, editor of the Sevens Report, said Friday that even the S&P 500 has held onto its week-to-date advance in large part thanks to Microsoft, Amazon and Apple. He and others have…Click here to read the full article.
“A combination of stimulus, positive trends in the virus, economic reopenings and hopes for a vaccine drove stocks higher in [the second quarter],” wrote Tom Essaye, founder of The Sevens Report. “As we begin [the third quarter], only one of those tailwinds is currently in place: Stimulus. That doesn’t mean we’ll see a correction…” Click here to read the full article.
According to Tom Essaye, founder of The Sevens Report, stocks could be missing a few “key ingredients” necessary for an even more extended rally. “A combination of 1) Stimulus, 2) Positive trends in the virus, 3) Economic reopenings and 4) Hopes for a vaccine drove stocks higher in Q2…” Essaye wrote. Click here to read the full article.
